Securities And Exchange Commission News
Most Popular Securities And Exchange Commission Story
SEC probes Schering trades on eve of Merck deal
Recall, if you can, the beginning of March, when Merck and Schering-Plough announced their $46 billion megamerger. At the time, a few intrepid folks pointed out a spike in Schering stock on Friday,... Read more...
Latest Headlines
- December 10, 2009
- September 29, 2009
- May 19, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
